- Home
- OP vs MYNZ Comparison
OP vs MYNZ Comparison
Compare OP & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OP
- MYNZ
- Stock Information
- Founded
- OP 2021
- MYNZ 2021
- Country
- OP Greece
- MYNZ Germany
- Employees
- OP N/A
- MYNZ N/A
- Industry
- OP
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- OP
- MYNZ Health Care
- Exchange
- OP Nasdaq
- MYNZ Nasdaq
- Market Cap
- OP 5.3M
- MYNZ 5.5M
- IPO Year
- OP N/A
- MYNZ 2021
- Fundamental
- Price
- OP $1.98
- MYNZ $1.37
- Analyst Decision
- OP
- MYNZ Buy
- Analyst Count
- OP 0
- MYNZ 2
- Target Price
- OP N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- OP 9.3M
- MYNZ 118.7K
- Earning Date
- OP 08-06-2025
- MYNZ 07-07-2025
- Dividend Yield
- OP N/A
- MYNZ N/A
- EPS Growth
- OP N/A
- MYNZ N/A
- EPS
- OP N/A
- MYNZ N/A
- Revenue
- OP $25,702,000.00
- MYNZ $893,991.00
- Revenue This Year
- OP N/A
- MYNZ $26.06
- Revenue Next Year
- OP N/A
- MYNZ $4.97
- P/E Ratio
- OP N/A
- MYNZ N/A
- Revenue Growth
- OP 35.58
- MYNZ N/A
- 52 Week Low
- OP $0.63
- MYNZ $1.34
- 52 Week High
- OP $3.17
- MYNZ $22.40
- Technical
- Relative Strength Index (RSI)
- OP 57.24
- MYNZ 23.25
- Support Level
- OP $1.82
- MYNZ $1.34
- Resistance Level
- OP $2.30
- MYNZ $1.48
- Average True Range (ATR)
- OP 0.48
- MYNZ 0.13
- MACD
- OP 0.08
- MYNZ -0.01
- Stochastic Oscillator
- OP 49.40
- MYNZ 3.72
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.